Furthermore, the expression of MAGE-C1/CT7 and/or MAGE-C2/CT10 in primary melanoma indicates a high risk of lymph node metastasis, which is of great clinical relevance as it identifies patients that require a strict follow-up. Here, MAGEC1 is linked to metastatic malignant neoplasm in the lymph nodes.